Tacrolimus

Organ Transplant Rejection

Tacrolimus is primarily used in combination with other medications to prevent the body's immune system from attacking and rejecting a newly transplanted organ. It is commonly prescribed for patients who have received the following types of transplants:

• Kidney
• Liver
• Heart
• Lung

By suppressing the immune response, the medication helps the body accept the donor organ so it can function properly. It is available in oral and injectable forms for these purposes.

Skin Conditions

A topical ointment form of tacrolimus is used to treat the symptoms of atopic dermatitis, also known as eczema. This treatment is generally reserved for adults and children who:

• Have not responded well to other types of skin treatments.
• Cannot use other medications due to side effects or medical history.

The ointment helps reduce skin inflammation, redness, and itching by affecting the immune system's activity in the skin.

Mechanism of Action

Tacrolimus belongs to a class of drugs known as calcineurin inhibitors. It works by blocking the action of certain cells in the immune system that would normally attack foreign substances or cause inflammation.

Preventing Organ Rejection

When used for organ transplants, tacrolimus helps prevent the body's immune system from attacking a new kidney, liver, heart, or lung. It does this by:

• Binding to specific proteins inside immune cells called T-lymphocytes.
• Inhibiting a substance called calcineurin, which is necessary for activating these immune cells.
• Stopping the production of chemical signals, such as interleukin-2, that tell the immune system to multiply and attack the transplanted organ.

Treating Skin Conditions

When applied to the skin as an ointment, tacrolimus works locally to treat moderate to severe atopic dermatitis (eczema). It alters the body's immune response to skin irritants, which helps reduce the redness, itching, and inflammation associated with the condition.

Common Side Effects

Common side effects vary depending on the form of the medication used. For those taking tacrolimus orally or by injection, common side effects include:

• Tremors or shaking
• Headache
• Diarrhea, nausea, or vomiting
• Stomach pain or constipation
• Difficulty falling or staying asleep
• Weakness, back pain, or joint pain
• Burning or tingling sensations in the hands or feet

For those using tacrolimus ointment on the skin, common side effects include:

• Stinging, burning, or itching at the application site
• Redness or skin irritation
• Acne
• Flu-like symptoms

Serious Side Effects

Tacrolimus can cause serious side effects that require immediate medical attention. These may include:

• Signs of infection, such as fever, cough, or sore throat
• Kidney issues, such as decreased urination or swelling of the legs and feet
• High blood sugar, which may cause extreme thirst or frequent urination
• High potassium levels
• Nervous system problems, including seizures, confusion, or vision changes
• Heart rhythm changes or chest pain
• Unusual bleeding or bruising
• Swollen glands or signs of a skin infection, such as pus or yellow crusts

Boxed Warnings

Tacrolimus carries boxed warnings regarding the risk of serious infections and malignancies. Because the medication suppresses the immune system, the body may be less able to fight off bacterial, viral, fungal, and protozoal infections. There is also an increased risk of developing lymphomas and other malignancies, particularly of the skin.

Kidney and Nervous System Effects

This medication can cause significant damage to the kidneys, known as nephrotoxicity. It may also affect the central nervous system, which is referred to as neurotoxicity. Symptoms of nervous system effects may include tremors, headaches, seizures, or changes in mental status.

Metabolic and Heart Concerns

• Diabetes: Some patients develop new-onset diabetes after transplantation while taking tacrolimus.
• Electrolytes: The drug may cause high potassium levels (hyperkalemia) or low magnesium levels.
• Heart Health: Tacrolimus can cause high blood pressure and, in some cases, heart rhythm issues or thickening of the heart muscle.

Topical Use Precautions

For the ointment form used for skin conditions, long-term continuous use should be avoided. It is important to limit exposure to natural or artificial sunlight, such as tanning beds, and to avoid applying the ointment to areas that may be cancerous or pre-cancerous.

Monitoring and Interactions

Regular blood tests are necessary to monitor drug levels, kidney function, and blood sugar. Patients are typically advised to avoid grapefruit and grapefruit juice, as these can significantly increase the concentration of tacrolimus in the blood to dangerous levels.

Pregnancy

Tacrolimus can cross the placenta and reach the developing fetus. Clinical data suggests that use during pregnancy may be associated with an increased risk of premature delivery and low birth weight. Some infants exposed to the medication in the womb have developed temporary kidney issues or high potassium levels after birth.

For transplant recipients, maintaining the health of the transplanted organ is critical during pregnancy. Healthcare providers typically evaluate whether the benefits of continuing the medication outweigh the potential risks to the fetus.

Breastfeeding

Tacrolimus is known to pass into breast milk. The impact on a nursing infant is not fully established. Patients are encouraged to discuss the risks and benefits of breastfeeding with their healthcare provider, as the amount of medication transferred can vary based on the dosage and the method of administration.

Oral Forms

Tacrolimus is available in several oral formulations used primarily to prevent organ rejection:

• Immediate-release capsules: These are standard capsules typically taken twice a day.
• Extended-release capsules and tablets: These formulations release the medication slowly over time and are usually taken once a day.
• Granules for oral suspension: This form is mixed with water to create a liquid, which is often used for patients who have difficulty swallowing pills.

Injectable Form

Tacrolimus is available as a solution for intravenous (IV) infusion. This form is generally reserved for use in a hospital setting for patients who are unable to take the medication by mouth.

Topical Form

For the treatment of certain skin conditions like eczema, tacrolimus is available as an ointment. This form is applied directly to the affected areas of the skin.

FDA-Approved Indications

Tacrolimus is approved by the U.S. Food and Drug Administration (FDA) for several specific medical uses depending on the form of the medication:

• Organ Transplantation: Oral and injectable forms are approved to prevent organ rejection in people receiving kidney, liver, or heart transplants. In 2021, the FDA expanded this approval to include lung transplant recipients based on real-world evidence.
• Atopic Dermatitis: The topical ointment form is approved as a second-line treatment for moderate to severe atopic dermatitis (eczema) in adults and children aged 2 years and older who have not responded well to other treatments.

Boxed Warnings

The FDA requires a boxed warning—its most serious type of warning—for tacrolimus due to the following risks:

• Infections and Malignancies: Systemic use (oral or injection) increases the risk of developing serious, sometimes fatal, bacterial, viral, fungal, and protozoal infections. It also increases the risk of developing lymphomas and other malignancies, particularly of the skin.
• Topical Safety Concerns: For the ointment form, the FDA warns that the long-term safety of calcineurin inhibitors has not been established. While a direct link is not proven, rare cases of skin cancer and lymphoma have been reported. It is intended for short-term or intermittent long-term use only and should not be used in children under 2 years of age.

Regulatory Status and Evidence

Tacrolimus was originally approved for liver transplants in 1994. Its recent approval for lung transplant rejection in 2021 was significant because the FDA utilized real-world evidence from observational studies to support the new indication, rather than relying solely on traditional clinical trials. The medication is available in both brand-name and generic versions.

Risks of Stopping Tacrolimus

Tacrolimus is typically used to prevent the body from rejecting a transplanted organ or to manage severe skin conditions. Stopping the medication abruptly or missing doses can have serious consequences:

• Organ Rejection: For transplant recipients, tacrolimus is vital for keeping the immune system from attacking the new organ. If you stop taking it, your immune system may begin to reject the transplant, which can be life-threatening.
• Return of Symptoms: When used topically for skin conditions like eczema, stopping the medication may cause symptoms to return or worsen.

Medical Supervision

Do not stop taking tacrolimus or change your dosage unless specifically instructed by your doctor. Transplant patients usually need to take immunosuppressant medications for the rest of their lives to ensure the transplant remains healthy. If you are experiencing side effects that make you want to stop the medication, consult your healthcare team immediately to discuss alternatives or dosage adjustments.

If you miss a dose, contact your doctor for instructions. Do not double the dose to catch up unless told to do so by a medical professional.